We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Horizon Signs Three Diagnostic Agreements Worth an Initial $3.3 Million

News   Nov 26, 2015

 
Horizon Signs Three Diagnostic Agreements Worth an Initial $3.3 Million
 
 
 

RELATED ARTICLES

Blood Test Accurately Predicts Sepsis Severity

News

Researchers at Cincinnati Children’s report in Science Translational Medicine that they have developed and successfully tested a new rapid blood assay that measures five biomarkers and accurately predicts which patients are at low, medium or high risk for death from sepsis.

READ MORE

A Blood Test Can Predict Brain Cancer Prognosis

News

In a new study researchers from the University of Pennsylvania are the first to demonstrate that glioblastoma (GBM) patients with a higher concentration of cell-free DNA (cfDNA) have a shorter progression-free survival after they are diagnosed compared to patients with less cfDNA, and that cfDNA concentrations increase in patients at the time of, or just before, their disease progresses.

READ MORE

New Diagnostic Method Finds Aggressive Tumours

News

Researchers at Karolinska Institutet in Sweden have developed a new cheap method that can identify highly heterogeneous tumours that tend to be very aggressive, and therefore need to be treated more aggressively.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE